James J. Huang's most recent trade in Adient plc was a trade of 3,017 Ordinary Shares done . Disclosure was reported to the exchange on Nov. 18, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adient plc | James J. Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 3,017 | 3,017 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | James J. Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 3,017 | 0 | - | - | Restricted Stock Units | |
| Adient plc | James J. Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 19.75 per share. | 18 Nov 2024 | 3,017 | 0 (0%) | 0% | 19.8 | 59,586 | Ordinary Shares |
| Adient plc | James J. Huang | EVP, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 98,039 | 98,039 | - | - | Restricted Stock Units | |
| Adient plc | James J. Huang | EVP, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 34,823 | 34,823 | - | - | Restricted Stock Units | |
| Adient plc | James J. Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 20.40 per share. | 14 Nov 2024 | 7,188 | 0 (0%) | 0% | 20.4 | 146,635 | Ordinary Shares |
| Adient plc | James J. Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 7,188 | 7,188 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | James J. Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 7,188 | 0 | - | - | Performance Share Units | |
| Adient plc | James J. Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 19.89 per share. | 14 Nov 2024 | 6,433 | 0 (0%) | 0% | 19.9 | 127,952 | Ordinary Shares |
| Adient plc | James J. Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 6,433 | 6,433 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | James J. Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 6,433 | 0 | - | - | Restricted Stock Units | |
| Adient plc | James J. Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 19.89 per share. | 14 Nov 2024 | 3,558 | 0 (0%) | 0% | 19.9 | 70,769 | Ordinary Shares |
| Adient plc | James J. Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 3,558 | 3,558 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | James J. Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 3,558 | 0 | - | - | Restricted Stock Units | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2023 | 40,086 | 40,086 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 32.83 per share. | 16 Nov 2023 | 40,086 | 0 (0%) | 0% | 32.8 | 1,316,023 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2023 | 40,086 | 0 | - | - | Performance Share Units | |
| Adient plc | Jian James Huang | EVP, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2023 | 19,494 | 19,494 | - | - | Restricted Stock Units | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2023 | 4,543 | 4,543 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 32.80 per share. | 16 Nov 2023 | 4,543 | 0 (0%) | 0% | 32.8 | 149,010 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2023 | 4,543 | 0 | - | - | Restricted Stock Units | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2023 | 3,599 | 0 | - | - | Restricted Stock Units | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2023 | 3,599 | 3,599 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 32.80 per share. | 16 Nov 2023 | 3,599 | 0 (0%) | 0% | 32.8 | 118,047 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2023 | 2,928 | 2,928 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 32.80 per share. | 16 Nov 2023 | 2,928 | 0 (0%) | 0% | 32.8 | 96,038 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2023 | 2,928 | 0 | - | - | Restricted Stock Units | |
| Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Windtree Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 2,224,616 | 2,224,616 | - | - | Warrants (right to purchase) | |
| Windtree Therapeutics Inc | James Z. Huang | Director | 22 Feb 2023 | 1,112,308 | 3,449,161 (10%) | 3% | 0.1 | 156,947 | Common Stock | |
| Windtree Therapeutics Inc | James Z. Huang | Director | 22 Feb 2023 | 1,112,308 | 0 | - | - | Warrants (right to purchase) | ||
| Windtree Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 1,112,308 | 1,112,308 | - | - | Warrants (right to purchase) | |
| Windtree Therapeutics Inc | James Z. Huang | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 498,008 | 0 | - | - | Warrants (right to purchase) | |
| Windtree Therapeutics Inc | James Z. Huang | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 275,938 | 0 | - | - | Warrants (right to purchase) | |
| Windtree Therapeutics Inc | James Z. Huang | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 275,862 | 0 | - | - | Warrants (right to purchase) | |
| Windtree Therapeutics Inc | James Z. Huang | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Feb 2023 | 62,500 | 0 | - | - | Warrants (right to purchase) | |
| Adient plc | Jian James Huang | EVP, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 10,784 | 10,784 | - | - | Restricted Stock Units | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2022 | 10,149 | 10,149 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 38.50 per share. | 17 Nov 2022 | 10,149 | 0 (0%) | 0% | 38.5 | 390,737 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2022 | 10,149 | 0 | - | - | Performance Share Units | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2022 | 8,032 | 0 | - | - | Restricted Stock Units | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2022 | 8,032 | 8,032 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 39.54 per share. | 17 Nov 2022 | 8,032 | 0 (0%) | 0% | 39.5 | 317,585 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2022 | 4,410 | 4,410 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 39.54 per share. | 17 Nov 2022 | 4,410 | 0 (0%) | 0% | 39.5 | 174,371 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2022 | 4,410 | 0 | - | - | Restricted Stock Units | |
| CASI Pharmaceuticals Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 4.28 per share. | 06 Sep 2022 | 33,300 | 371,517 (0%) | 0% | 4.3 | 142,627 | Common Stock |
| CASI Pharmaceuticals Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 3.89 per share. | 06 Sep 2022 | 19,162 | 335,106 (0%) | 0% | 3.9 | 74,601 | Common Stock |
| CASI Pharmaceuticals Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 06 Sep 2022 | 3,111 | 338,217 (0%) | 0% | 4.0 | 12,433 | Common Stock |
| CASI Pharmaceuticals Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 3.27 per share. | 19 Aug 2022 | 171,116 | 171,116 (0%) | 0% | 3.3 | 559,447 | Common Stock |
| CASI Pharmaceuticals Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 19 Aug 2022 | 40,000 | 234,221 (0%) | 0% | 3.5 | 139,992 | Common Stock |
| CASI Pharmaceuticals Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 3.46 per share. | 19 Aug 2022 | 23,105 | 194,221 (0%) | 0% | 3.5 | 80,038 | Common Stock |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 30.02 per share. | 01 Jul 2022 | 4,529 | 0 (0%) | 0% | 30.0 | 135,961 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 4,529 | 4,529 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2022 | 4,529 | 0 | - | - | Restricted Stock Units | |
| Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 80,000 | 188,333 (0%) | 0% | 0 | Common Stock | |
| Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 80,000 | 188,333 (0%) | 0% | 0 | Common Stock | |
| Windtree Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Windtree Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 5,000 | 296,281 (0%) | 0% | 0 | Common Stock | |
| CASI Pharmaceuticals Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 397,419 | 397,419 | - | - | Stock Option (Right to Buy) | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 222 | 0 | - | - | Stock Appreciation Rights | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.97 per share. | 15 Feb 2022 | 222 | 222 (0%) | 0% | 29.0 | 6,431 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 49.13 per share. | 15 Feb 2022 | 222 | 0 (0%) | 0% | 49.1 | 10,906 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2021 | 4,409 | 4,409 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2021 | 4,409 | 0 | - | - | Restricted Stock Units | |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 46.10 per share. | 19 Nov 2021 | 4,409 | 0 (0%) | 0% | 46.1 | 203,255 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2021 | 8,873 | 8,873 | - | - | Restricted Stock Units | |
| Windtree Therapeutics Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 19 Oct 2021 | 50,000 | 291,281 (0%) | 0% | 1.9 | 95,135 | Common Stock |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2021 | 812 | 0 | - | - | Restricted Stock Units | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2021 | 812 | 812 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 42.00 per share. | 01 Oct 2021 | 812 | 0 (0%) | 0% | 42.0 | 34,106 | Ordinary Shares |
| Alaunos Therapeutics Inc | James Z. Huang | Director | Purchase of securities on an exchange or from another person at price $ 1.71 per share. | 01 Sep 2021 | 100,000 | 108,333 (0%) | 0% | 1.7 | 171,000 | Common Stock |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 5,845 | 5,845 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 45.16 per share. | 01 Jul 2021 | 5,845 | 0 (0%) | 0% | 45.2 | 263,960 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 5,845 | 0 | - | - | Restricted Stock Units | |
| Adient plc | Jian James Huang | EVP, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 4,529 | 4,529 | - | - | Restricted Stock Units | |
| Windtree Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Windtree Therapeutics Inc | James Z. Huang | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.36 per share. | 31 Mar 2021 | 150,000 | 171,000 (0%) | 0% | 2.4 | 354,000 | Common Stock |
| Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 62,500 | 62,500 | - | - | Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | James Z. Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 8,333 | 8,333 (0%) | 0% | 0 | Common Stock | |
| Windtree Therapeutics Inc | James Z. Huang | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2021 | 5,845 | 5,845 | - | - | Restricted Stock Units | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2021 | 5,845 | 5,845 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 34.77 per share. | 01 Jan 2021 | 5,845 | 0 (0%) | 0% | 34.8 | 203,231 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2020 | 13,362 | 13,362 | - | - | Restricted Stock Units | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2020 | 91 | 91 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 27.84 per share. | 19 Nov 2020 | 91 | 0 (0%) | 0% | 27.8 | 2,533 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2020 | 91 | 0 | - | - | Performance Share Units | |
| Adient plc | Jian James Huang | EVP, APAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2020 | 91 | 91 | - | - | Performance Share Units | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2020 | 1,435 | 1,435 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2020 | 1,435 | 2,914 | - | - | Restricted Stock Units | |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 27.91 per share. | 18 Nov 2020 | 1,435 | 0 (0%) | 0% | 27.9 | 40,051 | Ordinary Shares |
| Windtree Therapeutics Inc | James Z. Huang | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.67 per share. | 23 Oct 2020 | 1,000 | 21,000 (0%) | 0% | 6.7 | 6,666 | Common Stock |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 788 | 788 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 19.41 per share. | 01 Oct 2020 | 788 | 0 (0%) | 0% | 19.4 | 15,295 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 788 | 812 | - | - | Restricted Stock Units | |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 164 | 164 (0%) | 0% | 0 | Ordinary Shares | |
| Adient plc | Jian James Huang | EVP, APAC | Sale or transfer of securities back to the company at price $ 19.86 per share. | 01 Oct 2020 | 164 | 0 (0%) | 0% | 19.9 | 3,257 | Ordinary Shares |
| Adient plc | Jian James Huang | EVP, APAC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 164 | 0 | - | - | Restricted Stock Units |